More IT, packaging vendors pile into the serialization space in anticipation of 2015 CA regulations
Antares Vision Srl partners with Xyntek, Inc. for US market
Even though serialization and track-and-trace rules did not make the final cut of the FDA Safety and Innovation Act signed into law in July, a growing number of pharma manufacturers and contract packagers are installing necessary hardware and software now. Part of the rationale is the upcoming e-pedigree rules scheduled to go into force in California in 2015 (these would have been superseded had federal legislation passed); and another factor is the growing number of countries outside the US that have implementation deadlines in place.
The latest set of players to enter the arena are Xyntek, Inc., a Yardley, PA, systems integrator with experience in packaging, quality management and regulatory support, which is partnering with Anatares Srl (Brescia, Italy), a machine-vision company serving the life sciences markets in Europe, South America and Asia. Antares claims to have more than 250 packaging lines using its machine vision and serialization technology. It also has a year-old partnership with Cognex, Inc. (Natick, MA), an industry leader in machine vision systems.
Serialization is a necessary first step to industry-wide track-and-trace systems, but by no means the sufficient step. Standardization among industry trading partners, and the willingness (or regulatory requirement) to share pedigree information are still to be worked out.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
